NCT00835406View on ClinicalTrials.gov

Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.

PHASE1CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

July 31, 2000

Study Completion Date

July 31, 2000

Conditions
Healthy
Interventions
DRUG

Alendronate Sodium Tablets 70mg

1 x 70mg, single dose fasting

DRUG

Fosamax® Tablets 70mg

1 x 70 mg, single dose fasting

Trial Locations (1)

GIV2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00835406 - Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions. | Biotech Hunter | Biotech Hunter